| |
|
|
|
|
| Slide Lecture Programs |
| 2006 Core Curriculum |
| Contemporary Management of Myocardial Ischemia |
May 17, 2006
|
| V: |
New Therapeutic Options for Chronic Stable Angina |
Slide 55 |
|
Download PowerPoint
|
MARISA: Tolerability of treatments
- The most common adverse events that occurred were dizziness, nausea, asthenia, and constipation.
- There was no difference in the onset of any adverse event between placebo and 500 mg bid of ranolazine. A dose-dependent relationship occurred in patients taking the highest doses of ranolazine.
|
|
|
Resources
